Active Pharmaceutical Ingredients (APIs)

  • Rotigotine*

    • API Product   :   

      Rotigotine*

    • CEP   :   

      -

    • WCC   :   

      -

    • Therapeutic Use    :   

      Anti-Parkinson Drugs; Analgesics; Anti-Epileptics

    • Originator   :   

      Abbott Laboratories

    • CAS No.    :   

      99755-59-6

    • Trade Name.   :   

      NEUPRO

    • Molecular Weight   :   

      315.48 g/ mol

    • Molecular Formula   :   

      C19H25NOS

    Application

    Rotigotine is also used to treat restless legs syndrome (RLS). Rotigotine is a dopamine agonist that works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

    General Description

    Rotigotine (trade name Neupro) is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS).[1][2] It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.[1][1] Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well.